These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7968204)

  • 1. [Immunologic aspects of disorders of neuromuscular transmission. 1. Myasthenia gravis].
    Andreis I; Lovnicki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):154-8. PubMed ID: 7968204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
    Andreis I; Lovnićki TJ; Beara N; Taradi M
    Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myasthenia gravis. Prototype of an anti-receptor autoaggression disease (author's transl)].
    Hohlfeld R; Wekerle H
    MMW Munch Med Wochenschr; 1981 Jul; 123(31):1207-11. PubMed ID: 6790965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenesis and pathophysiology of myasthenia gravis--electrophysiological, ultrastructural and immunological aspects of neuromuscular junctions (author's transl)].
    Takamori M; Tsujihata M; Ide Y; Eguchi K; Mine M
    No To Shinkei; 1980 Sep; 32(9):891-908. PubMed ID: 6254548
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenesis of myasthenia gravis].
    Téllez Zenteno JF; Morales Buenrostro LE; Torre Delgadillo A
    Rev Invest Clin; 2000; 52(1):80-5. PubMed ID: 10818814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune myasthenia gravis.
    Jayawant S; Parr J; Vincent A
    Handb Clin Neurol; 2013; 113():1465-8. PubMed ID: 23622368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myasthenia gravis, a model of organ-specific autoimmune disease.
    Berrih-Aknin S
    J Autoimmun; 1995 Apr; 8(2):139-43. PubMed ID: 7612144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of hyperacute experimental autoimmune myasthenia gravis. Acetylcholine receptor/cholinergic site/receptor function/autoimmunity.
    Mihovilovic M; Donnelly-Roberts D; Richman DP; Martinez-Carrion M
    J Immunol; 1994 Jun; 152(12):5997-6002. PubMed ID: 8207224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: a personal view of pathogenesis and mechanism, part 2.
    Simpson JA
    Muscle Nerve; 1978; 1(2):151-6. PubMed ID: 220530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Myasthenia, a model of a disease caused by auto-antibodies].
    Goulon M; Gajdos P; Goulon-Goëau C
    Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
    [No Abstract]   [Full Text] [Related]  

  • 14. [Physiopathology of myasthenia gravis. A review (author's transl)].
    Bergmans J
    Ann Chir; 1980 Mar; 34(3):147-57. PubMed ID: 6245616
    [No Abstract]   [Full Text] [Related]  

  • 15. Geoepidemiology of myasthenia gravis [corrected].
    Meyer A; Levy Y
    Autoimmun Rev; 2010 Mar; 9(5):A383-6. PubMed ID: 19922815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic pathology in patients with disorders of neuromuscular transmission].
    Kolomenskaia EA; Shagal DI; Strokov IA; Evseev VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(4):481-6. PubMed ID: 6730812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
    Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis.
    Zisimopoulou P; Lagoumintzis G; Kostelidou K; Bitzopoulou K; Kordas G; Trakas N; Poulas K; Tzartos SJ
    J Neuroimmunol; 2008 Sep; 201-202():95-103. PubMed ID: 18667243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anesthetic considerations for thymectomy in a patient having an anti-acetylcholine receptor antibody without myasthenia gravis].
    Koshida T; Hara K; Obara G; Sata T
    Masui; 2008 Aug; 57(8):993-5. PubMed ID: 18710007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.